Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid1–42
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 132 (1-2) , 49-59
- https://doi.org/10.1016/s0165-5728(02)00307-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Nasal Vaccination withβ-Amyloid Peptide for the Treatment of Alzheimer's DiseaseDNA and Cell Biology, 2001
- Number of Aβ Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque LevelsDNA and Cell Biology, 2001
- Duration and Specificity of Humoral Immune Responses in Mice Vaccinated with the Alzheimer's Disease-Associated β-Amyloid 1-42 PeptideDNA and Cell Biology, 2001
- β-Amyloid Peptide Vaccination Results in Marked Changes in Serum and Brain Aβ Levels in APPswe/PS1ΔE9 Mice, as Detected by SELDI-TOF-Based ProteinChip® TechnologyDNA and Cell Biology, 2001
- Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid depositionNeurobiology of Aging, 2001
- Nasal Aβ Treatment Induces Anti‐Aβ Antibody Production and Decreases Cerebral Amyloid Burden in PD‐APP MiceAnnals of the New York Academy of Sciences, 2000
- T-cell subsets (Th1 versus Th2)Annals of Allergy, Asthma & Immunology, 2000
- The role of B7 costimulation in T‐cell immunityImmunology & Cell Biology, 1999
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsThe Journal of Experimental Medicine, 1997
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996